Latest News

Kalbe Launches Vitek MS

The Newest Technology on Clinical Microbiology to Increase Healthcare Services

Kalbe Launches Vitek MS

Press Release No. 004/KFCP-DIR/PR/III/13

Jakarta, 28 March 2013 – PT Kalbe Farma Tbk (Kalbe) through its subsidiary PT Enseval Medika Prima (EMP)  is launching the Vitek Mass Spectrophotometry (Vitek MS) today, a medical device with a new technology in the microbiological test in the blood that would assist the enforcement of diagnosis and determination of the function of the use of antibiotics to be more precise and rational.

”EMP as part of Kalbe Group wishes realize a healthier Indonesia through the use of proper health equipment in treating diseases, said dr. George Kiongdo, Director of PT Enseval Medika Prima. ”Today, EMP celebrates its 16th year.  Alongside the celebration, we are launching the VITEK MS technology as a tool to test for microbiology in blood,”

”The technology for clinical microbiology is developing exponentially; in the old days, such test would take quite some time; nowadays with the new technology, it would only take two minutes to identify the existence of bacterial colony in blood," said Prof Amien Subandrio, Deputy of Research and Developmen of the Ministry of Healh of RI. “Nowadays blood tests hold a very crucial role in curing an ilness, particularly in determining the use of antibiotics on a patient.”

”An improper use of antibiotics could cause negative effecst to the body. If the dosage is too low, it could cause death because the disease is not countered, or the patient would have to face longer time to recover.  If the dosage is too high, the patient could develop resistance to the anibiotic, therefore the cost of the medication would also become more expensive," said Dr. Frans J Pangalila, SpPD(KIC) from Tarumanegara University, Faculty of Medicine.

Using conventional microbiology examination to identify the type of bacteria or virus that started with colonizing bacteries used to take 1 to 3 days, depending on the species of bacteria or virus.   Using the Vitek MS Technology, identification time could be shortened to two minutes per test. The promptness of bacteria/virus identification would greatly help healthcare professionals with the speed and accuracy of determining treatment for the patient. Therefore also providing speed in service and patient caretaking in general.

This device is a Fully Automated Microbiology Analyzer for Identification testing with Malditop technology, a technology developed in colaberation between the companies Biomerieux, France and Simadzu, Japan.

PT Enseval Medika Prima at a glance

PT Enseval Medika Prima (EMP), is a division of PT Enseval Putra Megatrading Tbk (EMPT) which is one of Kalbe's sub-business unit.. EMP is a healthcare equipment marketing company. EMP has four business units: hospital speciality (Hospec), hospital laboratory (HosLab), hospital support (Hos Port) dan Patient Care Management (PCM). Several of the brand-named products that has been distributed are: Biomeriux, ThermoScientific, General Electric, Bacton Dickinson, Covidien, Boston Scientific et cetera. EMP has 43 branches dispersed in 38 cities throughout Indonesia.

Kalbe at a glance

PT Kalbe Farma Tbk (“Kalbe”) was established in 1966 and is one of the biggest public pharmaceutical companies in Southeast Asia. Kalbe has four main divisions that handle their reliable and diversed brand portfolio, prescription drugs (Cefspan, Brainact, Broadced, etc); over-the-counter drugs (Woods, Promag, Mixagrip, Komix, Fatigon, etc); nutrition (ChilKid, Prenagen, Diabetasol, etc); and distribution business units.. Kalbe currently has more than 20 subsidiaries, 9 production facilities with international standard, and employs more than 15,000 employees and 4,000 sales force and marketing agents, dispersed across more than 65 branches throughout Indonesia.. From 1991, Kalbe is listed at Indonesia Stock Exchange (IDX:KLBF).

3231 Rate this article:

Please login or register to post comments.